Genomic analysis reveals distinctive molecular hallmarks in poorly differentiated and anaplastic thyroid cancers, highlighting drivers of aggressive tumor progression.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Landa et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: